Search results for "Allergy"

showing 10 items of 3181 documents

INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry

2021

Contains fulltext : 231528.pdf (Publisher’s version ) (Closed access) BACKGROUND: TNF receptor-associated periodic syndrome (TRAPS) is a rare autoinflammatory disease caused by dominant mutation of the TNF super family receptor 1A (TNFRSF1A) gene. Data regarding long-term treatment outcomes are lacking. OBJECTIVE: To assess correlations of genotype-phenotypes in patients with TRAPS, as defined by the International Study Group for Systemic Autoinflammatory Diseases (INSAID) classification and Eurofever criteria, with treatment responses. METHODS: Data from 226 patients with variants of the TNFRSF1A gene and enrolled in the Eurofever registry were classified according to the INSAID classifica…

medicine.medical_specialtyAbdominal painAutoinflammatory diseasesGroup AGroup BAA amyloidosis Anakinra Autoinflammatory diseases Colchicine TRAPS Abdominal Pain Colchicine FemaleHumans Mutation Registries Hereditary Autoinflammatory Diseases03 medical and health sciences0302 clinical medicineSettore MED/38 - Pediatria Generale E SpecialisticaAA amyloidosisTNF receptor-associated periodic syndrome (TRAPS) ; TNFRSF1A geneInternal medicinemedicineAA amyloidosisHumansImmunology and AllergyIn patientRegistries030212 general & internal medicineLikely pathogenicAnakinrabusiness.industryHereditary Autoinflammatory DiseasesTRAPSmedicine.diseaseAbdominal PainAnakinra030228 respiratory systemTNF receptor associated periodic syndromeMutationFemalemedicine.symptombusinessColchicineAA amyloidosis; Anakinra; Autoinflammatory diseases; Colchicine; TRAPSInflammatory diseases Radboud Institute for Molecular Life Sciences [Radboudumc 5]medicine.drug
researchProduct

Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency.

2011

Hereditary angioedema is a relatively rare genetic disorder affecting between one in 10,000 and one in 50,000 individuals worldwide. The most common clinical symptoms observed are relapsing swelling of the skin and abdominal pain attacks. However, more serious and potentially fatal laryngeal attacks can also occur. Hereditary angioedema is most frequently caused by a deficiency of C1-inhibitor. Replacement therapy with Berinert, an intravenous pasteurized C1-inhibitor concentrate derived from human plasma, is a recommended treatment for rapid resolution of acute attacks of hereditary angioedema due to C1-inhibitor deficiency. Prophylactic therapy with C1-inhibitor is also available. Future …

medicine.medical_specialtyAbdominal painC1 inhibitor deficiencyImmunologyComplement C1 Inactivator ProteinsC1-inhibitormedicineImmunology and AllergyHumansInfusions IntravenousAngioedemabiologybusiness.industryGenetic disorderAngioedemas Hereditaryfood and beveragesmedicine.diseaseDermatologyAbdominal PainHuman plasmaImmunologyHereditary angioedemabiology.proteinBerinert PPasteurizationmedicine.symptombusinessComplement C1 Inhibitor ProteinExpert review of clinical immunology
researchProduct

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

2021

Objective: An integrated analysis based on the Phase 2 TITAN (NCT01151423) and Phase 3 HERCULES (NCT02553317) studies with caplacizumab (CPLZ) in acquired thrombotic thrombocytopenic purpura (aTTP) was performed to assess treatment differences on efficacy and safety outcomes that may have been undetected in the individual trials. Methodology: In both trials, patients with an acute episode of aTTP were randomized to receive CPLZ or placebo (PBO) in addition to therapeutic plasma exchange (TPE) and immunosuppression. All randomized patients from both studies were included in the integrated efficacy analyses (CPLZ: n=108; PBO: n=112), and those who received at least 1 dose of the study drug we…

medicine.medical_specialtyAcquired Thrombotic Thrombocytopenic PurpuraExacerbationbusiness.industrymedicine.medical_treatmentHazard ratioImmunosuppressionHematologyPlaceboGastroenterologyRefractoryInternal medicinemedicineImmunology and AllergyDiseases of the blood and blood-forming organsPlateletRC633-647.5CaplacizumabbusinessHematology, Transfusion and Cell Therapy
researchProduct

IgG anti-endothelial cell antibodies (AECA) in type I diabetes mellitus; induction of adhesion molecule expression in cultured endothelial cells

1998

SUMMARYAECA were detected in 25 of 71 patients with type 1 diabetes mellitus and in two of 33 healthy subjects. Patients with diabetes of < 1 year duration and those with long-standing disease had the highest levels of these antibodies. Inhibition studies suggest that at least part of the AECA reactivity is due to cross-reactive anti-ssDNA antibodies. AECA-positive sera were able to increase intercellular adhesion molecule-1 (ICAM-1) and E-selectin on human umbilical vein endothelial cells (HUVEC). Increased binding of polymorphonuclear (PMN) cells was also found to accompany raised E-selectin expression. Soluble ICAM-1 and E-selectin were also found to be increased in the sera of AE…

medicine.medical_specialtyAdolescentNeutrophilsImmunologyIntercellular Adhesion Molecule-1GranulocyteUmbilical veinInternal medicineE-selectinCell AdhesionmedicineHumansImmunology and AllergyChildCells CulturedAutoantibodiesType 1 diabetesbiologybusiness.industryCell adhesion moleculeIntercellular Adhesion Molecule-1medicine.diseaseEndothelial stem cellDiabetes Mellitus Type 1medicine.anatomical_structureEndocrinologyChild PreschoolImmunoglobulin GImmunologybiology.proteinOriginal ArticleEndothelium VascularAntibodyE-SelectinbusinessClinical and Experimental Immunology
researchProduct

Muscle hypertrophy, strength development, and serum hormones during strength training in elderly women with fibromyalgia.

2005

To examine the effects of strength training on maximal force, cross-sectional area (CSA), and electromyographic (EMG) activity of muscles and serum hormone concentrations in elderly females with fibromyalgia (FM).Twenty-six patients with FM were randomly assigned to a training (FMT; n = 13; mean age 60 years) or a control (FMC; n = 13; 59 years) group. FMT performed progressive strength training twice a week for 21 weeks. The measurements included maximal isometric and concentric leg extension forces, EMG activity of the vastus lateralis and medialis, CSA of the quadriceps femoris, and serum concentrations of testosterone (T), free testosterone (FT), growth hormone (GH), insulin-like growth…

medicine.medical_specialtyAgingFibromyalgiaWeight LiftingStrength trainingImmunologyIsometric exerciseElectromyographySeverity of Illness IndexMuscle hypertrophychemistry.chemical_compoundDehydroepiandrosterone sulfateRheumatologyReference ValuesInternal medicineFibromyalgiamedicineImmunology and AllergyHumansHormone metabolismMuscle SkeletalTestosteronePhysical Therapy ModalitiesAgedProbabilitymedicine.diagnostic_testbusiness.industryElectromyographyGeneral MedicineHypertrophyMiddle Agedmedicine.diseaseHormonesExercise TherapyEndocrinologyCross-Sectional StudiesTreatment OutcomechemistryPhysical FitnessFemalebusinessFollow-Up StudiesScandinavian journal of rheumatology
researchProduct

Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review

2017

Background Guidelines and position papers indicate that allergen immunotherapy (AIT) is the only disease-modifying treatment, including prevention of the onset of new allergen sensitizations. However, this preventive effect was shown by only a few observational studies. Our aim was to systematically review the efficacy of AIT in preventing the onset of new allergen sensitizations. Methods Computerized bibliographic searches of MEDLINE, EMBASE, and the Cochrane Library (through June 2015) were supplemented with manual searches of reference lists. Observational studies or randomized controlled trials with a long-term observation period were included. Paired reviewers extracted data about stud…

medicine.medical_specialtyAllergen immunotherapyImmunologyMEDLINECochrane Librarymedicine.disease_causePlacebolaw.invention03 medical and health sciences0302 clinical medicineAllergensystematic reviewRandomized controlled triallawInternal medicineHypersensitivityOdds RatiomedicineAnimalsHumansImmunology and Allergy030212 general & internal medicinebusiness.industryAbsolute risk reductionasthmaAllergensImmunoglobulin ErhinoconjunctivitiSurgeryGRADETreatment Outcome030228 respiratory systemDesensitization Immunologicallergen immunotherapyImmunizationObservational studybusinessAllergy
researchProduct

Report on advances for pediatricians in 2018: allergy, cardiology, critical care, endocrinology, hereditary metabolic diseases, gastroenterology, inf…

2019

Abstract This review reported notable advances in pediatrics that have been published in 2018. We have highlighted progresses in allergy, cardiology, critical care, endocrinology, hereditary metabolic diseases, gastroenterology, infectious diseases, neonatology, nutrition, respiratory tract disorders and surgery. Many studies have informed on epidemiologic observations. Promising outcomes in prevention, diagnosis and treatment have been reported. We think that advances realized in 2018 can now be utilized to ameliorate patient care.

medicine.medical_specialtyAllergyAllergyCardiologyMEDLINEReviewRespiratory tract diseasePediatricsGastroenterologyPatient careHereditary metabolic diseasesUrinary Tract DiseasesEndocrinologyInternal medicineIntensive careHealth caremedicineHumansNeonatologyChildrenNutritionPublishingInfectious diseasebusiness.industryGastroenterologylcsh:RJ1-570lcsh:Pediatricsmedicine.diseaseSurgeryCritical careEndocrinologyBibliometricsRespiratory tract disordersCardiologyInfectious diseasesSurgeryPeriodicals as TopicNeonatologyRespiratory tract disorderbusinessHereditary metabolic diseaseItalian Journal of Pediatrics
researchProduct

Helicobacter pylori Infection and Risk Factors in Relation to Allergy in Children

2017

Purpose To analyze presence of Helicobacter pylori infection and environmental risk factors among children with and without allergy. Methods Parents of children at primary health care centres/kindergartens and allergologist consultation were asked to answer a questionnaire and to bring a faecal sample. H. pylori infection was detected by monoclonal stool antigen test. Prevalence of H. pylori infection and risk factors were compared between individuals with and without allergy using χ2 test, ANOVA test and parameters and logistic regression. Results Among 220 children (mean age, 4.7 years; ±standard deviation 2.3 years) H. pylori positivity was non-significantly lower among patients with all…

medicine.medical_specialtyAllergyAllergymedicine.medical_treatmentLogistic regression03 medical and health sciences0302 clinical medicineInternal medicineMedicineCaesarean section030212 general & internal medicineFamily historyHepatologybiologyHelicobacter pyloribusiness.industryGastroenterologyOdds ratioHelicobacter pylorimedicine.diseasebiology.organism_classificationConfidence interval030228 respiratory systemRisk factorsPediatrics Perinatology and Child HealthOriginal ArticlebusinessBreast feedingPediatric Gastroenterology, Hepatology & Nutrition
researchProduct

Cutaneous and Allergic reactions due to COVID‐19 vaccinations: A review

2021

ABSTRACT Introduction The pandemic caused by the novel coronavirus disease 2019 (COVID‐19) has had an unprecedented impact on the overall health and the global economy. Vaccination is currently the most dependable strategy to end the pandemic, despite the slower‐than‐hoped‐for rollout, particularly for low‐to‐middle‐income countries, and the uncertain duration of protection afforded by vaccination. The spike protein of the virus (immunodominant antigen of the virus) is the main target of the approved and candidate SARS‐CoV‐2 vaccines. This protein binds to the ACE2 receptor of the host cell, initiating the entry of the virus into the cell and the chain of subsequent events ending to Acute R…

medicine.medical_specialtyAllergyCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)ExacerbationReview ArticleDermatologyallergic reactionsmedicine.disease_causeSARS‐CoV‐2VirusAntigenCOVID‐19PandemicHypersensitivityHumansMedicineIntensive care medicineReview ArticlesCoronavirusbusiness.industryVaccinationCOVID-19cutaneous reactionsmedicine.diseaseVaccinationBNT162b2mRNA VaccinesbusinessJournal of Cosmetic Dermatology
researchProduct

The spectrum of allergic (cross-)sensitivity in clinical patch testing with 'para amino' compounds

2002

Background: Allergic contact sensitization to ‘para amino’ compounds is frequent and the spectrum of cross-reactivity between members of this chemical group is variable. Methods: A retrospective analysis of clinical patch test data obtained with a special test series in the centres of the Information Network of Departments of Dermatology (IVDK) between 1995 and 1999. Results: In the 638 patients tested with the above test panel positive reactions were observed most often to p-aminoazobenzene (16.2%), p-phenylenediamine (14.1%), p-toluylenediamine (10.0%), followed by 4,4′-diaminodiphenylmethane (8.5%), Disperse Orange 3 (8.4%) and p-aminophenol (3.1%). Among the 544 patients tested with p-p…

medicine.medical_specialtyAllergyConcordanceCross sensitivityStatistics as TopicImmunologyCross ReactionsPhenylenediaminesAminophenolsmedicine.disease_causeCross-reactivity030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compoundSulfanilamide0302 clinical medicineGermanySulfanilamidesmedicineHumansImmunology and AllergyAminesRetrospective Studiesbusiness.industryPatch testp-PhenylenediamineAllergensPatch Testsmedicine.diseaseDermatology3. Good healthchemistryP-Aminoazobenzenep-Aminoazobenzene030220 oncology & carcinogenesisDermatitis Allergic ContactImmunologybusiness4-Aminobenzoic AcidContact dermatitisAllergy
researchProduct